Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Texcell
Evry, Île-de-France, France
- Ownership
- Private
- Employees
- ~72
- Development stage
- Other
01
Overview
Texcell delivers biosafety and viral safety testing (GLP and GMP compliant), cell banking, viral validation, and immunomonitoring for global biopharma, enabling safe development of biologics, cell therapies, and related products[1][2][3][4][5][6][7].
- Therapeutic areas
- Other
- Modalities
- BiologicCell therapyGene therapyMedical deviceMonoclonal antibodyRecombinant protein
- Industry
- Contract Research Organization
02
Partnerships
Collaborates with global biopharma and medical device companies
Beyond the preview
Go deeper on Texcell.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Texcell.